Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

1.1k indexed citations

Abstract

loading...

About

This paper, published in 2006, received 1.1k indexed citations. Written by Andrew T. Parsa, James S. Waldron, Amith Panner, Courtney A. Crane, Ian F. Parney, Jeffrey J. Barry, Joseph C. Murray, Tarık Tihan, Michael C. Jensen and Paul S. Mischel covering the research area of Oncology and Immunology. It is primarily cited by scholars working on Oncology (866 citations), Immunology (620 citations) and Molecular Biology (210 citations). Published in Nature Medicine.

In The Last Decade

doi.org/10.1038/nm1517 →

Countries where authors are citing Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

Specialization
Citations

This map shows the geographic impact of Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma more than expected).

Fields of papers citing Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm1517.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026